7.57
Precedente Chiudi:
$7.55
Aprire:
$7.46
Volume 24 ore:
117.19K
Relative Volume:
0.80
Capitalizzazione di mercato:
$46.83M
Reddito:
$16.03M
Utile/perdita netta:
$-18.83M
Rapporto P/E:
-2.1629
EPS:
-3.5
Flusso di cassa netto:
$-14.87M
1 W Prestazione:
+25.75%
1M Prestazione:
+4.63%
6M Prestazione:
-33.48%
1 anno Prestazione:
+33.98%
Electrocore Inc Stock (ECOR) Company Profile
Nome
Electrocore Inc
Settore
Industria
Telefono
973-290-0097
Indirizzo
200 FORGE WAY, ROCKAWAY
Confronta ECOR con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
![]()
ECOR
Electrocore Inc
|
7.57 | 46.83M | 16.03M | -18.83M | -14.87M | -3.50 |
![]()
ABT
Abbott Laboratories
|
128.85 | 225.27B | 41.95B | 13.40B | 6.35B | 7.65 |
![]()
BSX
Boston Scientific Corp
|
101.90 | 138.41B | 17.55B | 2.03B | 2.37B | 1.37 |
![]()
SYK
Stryker Corp
|
365.06 | 129.62B | 22.60B | 2.99B | 3.49B | 7.76 |
![]()
MDT
Medtronic Plc
|
84.16 | 107.92B | 33.20B | 4.26B | 5.47B | 3.29 |
![]()
EW
Edwards Lifesciences Corp
|
76.04 | 40.53B | 5.54B | 4.18B | 259.90M | 7.00 |
Electrocore Inc Stock (ECOR) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2020-08-14 | Aggiornamento | BTIG Research | Neutral → Buy |
2019-11-14 | Downgrade | JMP Securities | Mkt Outperform → Mkt Perform |
2019-09-26 | Ripresa | Cantor Fitzgerald | Neutral |
2019-05-30 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
2019-05-15 | Downgrade | BTIG Research | Buy → Neutral |
2019-05-09 | Iniziato | Noble Capital Markets | Outperform |
2018-09-21 | Iniziato | Cantor Fitzgerald | Overweight |
Mostra tutto
Electrocore Inc Borsa (ECOR) Ultime notizie
Press Release Distribution & PR Platform - ACCESS Newswire
electroCore (NASDAQ:ECOR) Shares Up 14.6% – Here’s What Happened - Defense World
Vagus Nerve Stimulators Market Set to Witness Significant - openPR.com
ElectroCore (ECOR) Reports Positive Outcomes for Traumatic Brain Injury Treatment | ECOR Stock News - GuruFocus
electroCore announces new data presented on nVNS - TipRanks
electroCore, Inc. Reports Positive Data on gammaCore® for Treating Concussive Symptoms in Mild Traumatic Brain Injury at 2025 IBIA World Congress - Nasdaq
gammaCore Non-Invasive Vagus Nerve Stimulation (nVNS) Shown - GlobeNewswire
Breakthrough Study: Non-Invasive Brain Treatment Relieves 22 Concussion Symptoms in Major Clinical Trial - Stock Titan
electroCore to Participate at the Planet MicroCap Showcase - GlobeNewswire
Vagus Nerve Stimulators Market Deep Research Report with - openPR.com
Electrocore at 24th Annual Needham Virtual Healthcare Conference: Strategic Expansion Plans - Investing.com Australia
ElectroCore stock hits 52-week low at $5.3 amid challenges - Investing.com
ElectroCore stock hits 52-week low at $5.3 amid challenges By Investing.com - Investing.com South Africa
electroCore appoints new independent accounting firm By Investing.com - Investing.com Australia
electroCore appoints new independent accounting firm - Investing.com
electroCore Named One of The Americas’ Fastest Growing Companies by the Financial Times - GlobeNewswire
Financial Times Names electroCore #16 Fastest-Growing Healthcare Company in Americas - Stock Titan
Vagus Nerve Stimulators Market Size, Growth Trends and Report - openPR.com
electroCore to Participate at the Needham Virtual Healthcare Conference - The Manila Times
electroCore Showcases Breakthrough Bioelectronic Medicine Platform: CEO Headlines Needham Conference - Stock Titan
NeuroMetrix, Inc. SEC 10-K Report - TradingView
electroCore secures new VA contract through 2030 - Investing.com India
electroCore secures new VA contract through 2030 By Investing.com - Investing.com UK
electroCore Extends VA Contract for Five Years - GlobeNewswire
electroCore Wins Massive VA Deal While 585 Others Get Cut - Stock Titan
(ECOR) Technical Data - news.stocktradersdaily.com
NeuroMetrix shareholders approve merger with electroCore By Investing.com - Investing.com Australia
Market Cool On electroCore, Inc.'s (NASDAQ:ECOR) Revenues Pushing Shares 59% Lower - simplywall.st
NeuroMetrix shareholders approve merger with electroCore - Investing.com
Insider Buying: Thomas Errico Acquires 6,000 Shares of electroCo - GuruFocus.com
Trend Tracker for (ECOR) - news.stocktradersdaily.com
Vagus Nerve Stimulators Market is Expected to Witness Positive Growth With A CAGR of 9.06% by 2030, estimates DelveInsight - The Globe and Mail
Vagus Nerve Stimulators Market is Expected to Witness Positive - openPR.com
electroCore CEO Daniel Goldberger acquires $8,590 in stock By Investing.com - Investing.com Australia
electroCore CEO Daniel Goldberger acquires $8,590 in stock - Investing.com India
While shareholders of electroCore (NASDAQ:ECOR) are in the black over 1 year, those who bought a week ago aren't so fortunate - Simply Wall St
Q1 Earnings Estimate for electroCore Issued By HC Wainwright - Defense World
electroCore (NASDAQ:ECOR) Earns “Buy” Rating from HC Wainwright - Defense World
electroCore FY2028 EPS Forecast Increased by HC Wainwright - Defense World
LADENBURG THALM/SH SH Has Lowered Expectations for electroCore (NASDAQ:ECOR) Stock Price - Defense World
Earnings call transcript: ElectroCore Q4 2024 sees revenue rise, stock dips By Investing.com - Investing.com South Africa
H.C. Wainwright maintains Buy on electroCore stock, $25 target By Investing.com - Investing.com India
electroCore, Inc. (NASDAQ:ECOR) Q4 2024 Earnings Call Transcript - Insider Monkey
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
Electrocore Inc Azioni (ECOR) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):